Prognostic value of myositis-specific antibodies in patients with idiopathic interstitial pneumonia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Prognostic value of myositis-specific antibodies in patients with idiopathic interstitial pneumonia ; volume:24 ; number:1 ; day:10 ; month:10 ; year:2024 ; pages:1-8 ; date:12.2024
BMC pulmonary medicine ; 24, Heft 1 (10.10.2024), 1-8, 12.2024
- Urheber
-
Wakabayashi, Hiroki
Iwasaki, Kotaro
Murakami, Yu
Takashima, Kenta
Kaneko, Kaichi
Matsuzawa, Yasuo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-024-03326-w
- URN
-
urn:nbn:de:101:1-2412272121561.267664907921
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wakabayashi, Hiroki
- Iwasaki, Kotaro
- Murakami, Yu
- Takashima, Kenta
- Kaneko, Kaichi
- Matsuzawa, Yasuo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Role of anti-DFS70 antibodies in idiopathic interstitial pneumonia and in connective tissue disease associated interstitial lung disease
Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
Utility of Anti-DSF70 antibodies to predict connective tissue disease in patients originally presenting with idiopathic interstitial pneumonia
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review
Analytic Morphomics in Myositis-Related Interstitial Lung Disease
Expression of HSP47 in Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia
Serum level of transforming growth factor-beta1 in major idiopathic interstitial pneumonia
Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia
Myositis-specific antibodies: Overview and clinical utilization
Usual interstitial pneumonia coexisted with nonspecific interstitial pneumonia, What’s the diagnosis?
Role of anti-DFS70 antibodies in idiopathic interstitial pneumonia and in connective tissue disease associated interstitial lung disease
Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
Utility of Anti-DSF70 antibodies to predict connective tissue disease in patients originally presenting with idiopathic interstitial pneumonia
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review
Analytic Morphomics in Myositis-Related Interstitial Lung Disease
Expression of HSP47 in Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia
Serum level of transforming growth factor-beta1 in major idiopathic interstitial pneumonia
Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia
Myositis-specific antibodies: Overview and clinical utilization
Usual interstitial pneumonia coexisted with nonspecific interstitial pneumonia, What’s the diagnosis?
Role of anti-DFS70 antibodies in idiopathic interstitial pneumonia and in connective tissue disease associated interstitial lung disease
Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
Utility of Anti-DSF70 antibodies to predict connective tissue disease in patients originally presenting with idiopathic interstitial pneumonia
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review
Analytic Morphomics in Myositis-Related Interstitial Lung Disease
Expression of HSP47 in Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia
Serum level of transforming growth factor-beta1 in major idiopathic interstitial pneumonia
Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia
Myositis-specific antibodies: Overview and clinical utilization